Luminai Secures $38 Million Series B to Scale AI Automation for Health Systems

New updates have been reported about Luminai.

Luminai has raised $38 million in Series B funding to accelerate deployment of its AI-native automation platform across large health systems, bringing total capital raised to $60 million and signaling growing institutional confidence in its model for overhauling administrative operations. The round was led by Peak XV Partners, with participation from Define Ventures and existing backers including General Catalyst and Y Combinator, and is aimed at meeting demand from providers facing cost pressure, staffing shortages, and complex, fragmented workflows.

Positioning itself as an orchestration layer rather than a collection of point tools, Luminai applies healthcare-trained AI to interpret unstructured data and execute end-to-end workflows across access, revenue cycle, compliance, and other administrative functions that contribute to an estimated 25% of total healthcare spending. CEO Kesava Kirupa Dinakaran said recent advances in AI now allow the company to encode previously manual, cross-system coordination into software that learns from operational context, and the new capital will be used to expand product capabilities, grow engineering and deployment teams, and onboard additional enterprise customers, supported by talent drawn from leading technology and health IT organizations.